Pure Biologics Spólka Akcyjna (PUR) — Cash Flow Reinvestment Rate
Pure Biologics Spólka Akcyjna (PUR) has a Cash Flow Reinvestment Rate of 0.05x as of March 2024, reinvesting zł96.00K (capex zł85.00K plus investments zł-11.00K) from operating cash flow of zł2.04 Million. Check Pure Biologics Spólka Akcyjna cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pure Biologics Spólka Akcyjna Cash Flow Reinvestment Rate (2019–2019)
Historical reinvestment intensity for Pure Biologics Spólka Akcyjna across 1 annual periods. Explore investment intensity of Pure Biologics Spólka Akcyjna to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Pure Biologics Spólka Akcyjna (2019–2019)
Year-by-year capital reinvestment analysis for Pure Biologics Spólka Akcyjna. For live market cap and broader valuation context, see Pure Biologics Spólka Akcyjna market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 5.24x | zł27.97 Million | zł5.33 Million | zł161.92K | — |